RecruitingNCT06653660

Exposure to Organochlorine Pollutants and Impact on Development in the Peripubertal Age in Guadeloupe


Sponsor

Centre Hospitalier Universitaire de la Guadeloupe

Enrollment

650 participants

Start Date

Dec 19, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

In the context of environmental pollution of the French West Indies by chlordecone and questions about health consequences, monitoring at the peripubertal age of children born alive in the TIMOUN cohort is justified in several respects: - existence of an already established mother-child cohort whose live-born children will reach peripubertal ages during the period 2020-2022; - opportunity to verify hypotheses put forward on the basis of toxicological data acquired in laboratory animals and the hormonal characteristics of chlordecone (endocrine disruptor); - strong societal demand for such research to be carried out because of concerns about the sensitivity of children and adolescents to the effects of environmental xenobiotics, in particular on sexual development and the age of puberty; - recommendation of the Scientific Council Chlordecone Inserm - InVS; specific action of the National Plan Chlordecone IV.


Eligibility

Min Age: 16 YearsMax Age: 22 Years

Inclusion Criteria5

  • Be born to a mother whose pregnancy was included in the Timoun cohort (2004 - 2007) and whose parents agreed to be contacted later.
  • Residing in Guadeloupe at the peripubertal age
  • Affiliation to a social security scheme
  • Agreement to participate in the study and informed consent signed by the minor
  • Study participation agreement and informed consent signed by the parents

Exclusion Criteria1

  • Refusal to participate in the research

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERClinical examination

For the aim of the present study, we will follow-up children born alive in the TIMOUN cohort at peripubertal age. Questionnaires will be administered to parents on the child's health and lifestyle. Stature-weight anthropometric and cardio-dynamic measurements of the child will be obtained. Scores on three cognitive tests will be obtained. Furthermore, steroid hormones and chlordecone in the child's peripheral blood will be determined.


Locations(1)

CHU of Guadeloupe

Pointe-à-Pitre, Guadeloupe, Guadeloupe

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06653660